Announcements Trials

Browse Landscape

Phase

Status

Completed 10 Unknown 3 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Castrate Resistant Prostate Cancer 1

Interventions

Cyclophosphamide 389 Carboplatin 343 Gemcitabine 331 pembrolizumab 328 Cisplatin 327 Paclitaxel 294 Radiotherapy 291 Docetaxel 285 Bevacizumab 249 Rituximab 233 Capecitabine 221 Nivolumab 218 Dexamethasone 205 Fluorouracil 189 fludarabine 177 Oxaliplatin 177 Pemetrexed 153 Doxorubicin 152 Irinotecan 147 Etoposide 144 Leucovorin 143 Cytarabine 133 Bortezomib 129 fludarabine phosphate 128 Cetuximab 126 Lenalidomide 125 Filgrastim 119 Erlotinib Hydrochloride 119 Temozolomide 111 Radiosurgery 110

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interventional × Lenograstim × Clear all

NCT01907009 2023-04-19

MEL-CAP

Barts & The London NHS Trust

Phase 2/3 Terminated

Castrate Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡